Literature DB >> 14634036

Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.

Cedric Moro1, Jean Galitzky, Coralie Sengenes, François Crampes, Max Lafontan, Michel Berlan.   

Abstract

A lipolytic pathway involving natriuretic peptides has recently been discovered in human fat cells. Its functional characteristics and the interactions of the atrial natriuretic peptide (ANP)-induced effects with adrenergic and insulin pathways were studied. Characterization of the action of ANP antagonists, i.e., A71915, anantin, S-28-Y (Ser-28-Tyr, a synthesized peptide), and HS-142-1 (a microbial polysaccharide), was performed. Lipolytic assays and intracellular cGMP and cAMP determinations were performed on isolated fat cells. Cell membranes were used for binding studies. At low concentrations ANP and isoproterenol [beta-adrenergic receptor (beta-AR) agonist] exerted additive lipolytic effects. The alpha(2)-AR pathway did not interfere with that of ANP. Lipolytic effects of ANP were unaltered by a 2-h pretreatment of fat cells with insulin, whereas beta-AR-induced lipolysis was reduced. Homologous desensitization occurred for ANP-dependent lipolytic pathways. Dendroapsis natriuretic peptide exhibited a similar maximal effect but a 10-fold higher lipolytic potency than ANP and mini-ANP (the shortest form of ANP). The antagonist A71915 exhibited competitive antagonistic properties with a pA(2) value of 7.51. Anantin displayed noncompetitive antagonism and exerted an inhibitory action on basal and beta-adrenergic receptor-induced lipolytic response. S-28-Y exhibited antagonist potencies toward ANP-induced lipolysis and behaved as a partial lipolytic agonist with a lower pD(2) value (7.4 +/- 0.2) than ANP (9.4 +/- 0.3). HS-142-1 exerted the weakest antagonistic effects. The results demonstrate that ANP-dependent effects do not interfere with beta- and alpha(2)-adrenergic pathways in human fat cells. They are unaffected by insulin pretreatments of fat cells but undergo desensitization. In the search of potent and specific natriuretic peptide receptor-A antagonist, in the human fat cell, A71915 was the only reliable one found.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14634036     DOI: 10.1124/jpet.103.060913

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

1.  Opposite effects of ANP receptors in attenuation of LPS-induced endothelial permeability and lung injury.

Authors:  Junjie Xing; Bakhtiyor Yakubov; Valeriy Poroyko; Anna A Birukova
Journal:  Microvasc Res       Date:  2011-10-06       Impact factor: 3.514

Review 2.  Neural innervation of white adipose tissue and the control of lipolysis.

Authors:  Timothy J Bartness; Yang Liu; Yogendra B Shrestha; Vitaly Ryu
Journal:  Front Neuroendocrinol       Date:  2014-04-13       Impact factor: 8.606

3.  Atrial natriuretic peptide regulates adipose tissue accumulation in adult atria.

Authors:  Nadine Suffee; Thomas Moore-Morris; Patrick Farahmand; Catherine Rücker-Martin; Gilles Dilanian; Magali Fradet; Daigo Sawaki; Geneviève Derumeaux; Pascal LePrince; Karine Clément; Isabelle Dugail; Michel Puceat; Stéphane N Hatem
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

4.  Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation.

Authors:  Andreas L Birkenfeld; Michael Boschmann; Cedric Moro; Frauke Adams; Karsten Heusser; Jens Tank; André Diedrich; Christoph Schroeder; Gabi Franke; Michel Berlan; Friedrich C Luft; Max Lafontan; Jens Jordan
Journal:  J Clin Endocrinol Metab       Date:  2006-09-19       Impact factor: 5.958

Review 5.  Insulin signalling mechanisms for triacylglycerol storage.

Authors:  M P Czech; M Tencerova; D J Pedersen; M Aouadi
Journal:  Diabetologia       Date:  2013-02-27       Impact factor: 10.122

Review 6.  Antiobesity pharmacotherapy: new drugs and emerging targets.

Authors:  G W Kim; J E Lin; E S Blomain; S A Waldman
Journal:  Clin Pharmacol Ther       Date:  2013-10-08       Impact factor: 6.875

7.  Culture effects of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) on cryopreserved human adipose-derived stromal/stem cell proliferation and adipogenesis.

Authors:  Teddi L Hebert; Xiying Wu; Gang Yu; Brian C Goh; Yuan-Di C Halvorsen; Zhong Wang; Cedric Moro; Jeffrey M Gimble
Journal:  J Tissue Eng Regen Med       Date:  2009-10       Impact factor: 3.963

8.  Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.

Authors:  C Moro; E Klimcakova; M Lafontan; M Berlan; J Galitzky
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

9.  Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome.

Authors:  Cedric Moro; Magdalena Pasarica; Karen Elkind-Hirsch; Leanne M Redman
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

10.  Different regulation of atrial ANP release through neuropeptide Y2 and Y4 receptors.

Authors:  Feng Lian Piao; Kuichang Yuan; Guang Yi Bai; Jeong Hee Han; Woo Hyun Park; Suhn Hee Kim
Journal:  J Korean Med Sci       Date:  2008-12-24       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.